BioClinica
BioClinica
BioClinica
Are you from BioClinica?
  • Super opportunity to hear from Bioclinica's VP, Quality & Regulatory Affairs Todd Kisner during Immuno-Oncology 360. Todd will speak on "Inspection Readiness for Imaging Data" in the Operational Aspects for Immunotherapy Imaging plenary session on Feb. 8 chaired by Merck's Andrea Perrone MD, Associate VP, Clinical Imaging Translational Medicine. Details here: http://ow.ly/PNrF30i5BHL
  • Monitoring of adverse event cases is an important part of post-marketing of an approved drug. When a patient reports a potential adverse event to a physician, regulatory agency, or the sponsor, the event must be reviewed, aggregated with similar cases in the databases or literature, and reported to the regulatory agency in a timely manner. Check out how one Bioclinica client, a large sponsor in Japan, accomplishes the task http://ow.ly/kBar30hbefb
  • Still using spreadsheets to manage the clinical supply chain in clinical trials? Here's a better way to forecast and manage supply needs no matter how complex the variables. Access the Bioclinica eBook to learn how. http://ow.ly/vvO530hxKnW
  • CenterWatch names Bioclinica's RTSM lead, Kevin Bishop, a 'Top Innovator' changing the face of the clinical trials industry. Check out how the team Kevin leads is reducing risk to the clinical supply chain through advanced optimization techniques. Congratulations Kevin and our entire RTSM team and all of the Top Innovators recognized this year! http://ow.ly/2Lv730hPFPD

Super opportunity to hear from Bioclinica's VP, Quality & Regulatory Affairs Todd Kisner during Immuno-Oncology 360. Todd will speak on "Inspection Readiness for Imaging Data" in the Operational Aspects for Immunotherapy Imaging plenary session on Feb. 8 chaired by Merck's Andrea Perrone MD, Associate VP, Clinical Imaging Translational Medicine. Details here: http://ow.ly/PNrF30i5BHL

Monitoring of adverse event cases is an important part of post-marketing of an approved drug. When a patient reports a potential adverse event to a physician, regulatory agency, or the sponsor, the event must be reviewed, aggregated with similar cases in the databases or literature, and reported to the regulatory agency in a timely manner. Check out how one Bioclinica client, a large sponsor in Japan, accomplishes the task http://ow.ly/kBar30hbefb

Still using spreadsheets to manage the clinical supply chain in clinical trials? Here's a better way to forecast and manage supply needs no matter how complex the variables. Access the Bioclinica eBook to learn how. http://ow.ly/vvO530hxKnW

CenterWatch names Bioclinica's RTSM lead, Kevin Bishop, a 'Top Innovator' changing the face of the clinical trials industry. Check out how the team Kevin leads is reducing risk to the clinical supply chain through advanced optimization techniques. Congratulations Kevin and our entire RTSM team and all of the Top Innovators recognized this year! http://ow.ly/2Lv730hPFPD

14 jobs at BioClinica

Jobs in